| Step | Action | Key Points |
|---|---|---|
| 1 — Airway | Supplemental oxygen; intubate if airway unprotected or ventilation inadequate | Do not await drug identification. Use capnography — pulse oximetry alone is delayed indicator of hypoventilation. |
| 2 — Reversal | Flumazenil in carefully selected cases only | Contraindicated if dependent, prior TCA co-ingestion, seizure history. No reversal agent for barbiturates, Z-drugs, or propofol. |
| 3 — Supportive care | Maintain ventilation, treat hypotension, correct hypothermia | Foundation of management. Monitor for aspiration and rhabdomyolysis. |
| 4 — Phenobarbital | Multiple-dose activated charcoal + urinary alkalinization | Multi-dose activated charcoal (every 4–6 hours) interrupts enterohepatic recirculation. Sodium bicarbonate targets urine pH 7.5–8.0 for ion-trapping. |
Isolated benzodiazepine overdose rarely causes fatal respiratory arrest. Opioid co-ingestion produces additive to synergistic respiratory depression — benzodiazepines are co-detected in 30 to 75 percent of opioid overdose fatalities. Mixed overdose is the rule, not the exception, in clinical series.
| Agent | Best For | Rationale |
|---|---|---|
| Diazepam or chlordiazepoxide | Medically stable patients, no hepatic disease | Self-tapering long half-life. Reduces management complexity. Preferred first-line. |
| Lorazepam or oxazepam (LOT agents) | Hepatic disease, elderly, high accumulation risk | Glucuronidation only, no active metabolites. Predictable offset. More frequent dosing required. |
| Phenobarbital loading (IV) | Moderate to severe withdrawal, benzodiazepine-refractory | Directly activates GABA-A channels (bypasses receptor downregulation); inhibits AMPA receptors; 80–120 hour half-life provides sustained coverage. |
Give thiamine 500 mg intravenously before or with any glucose-containing fluid in patients with alcohol use disorder. Glucose before thiamine in a thiamine-depleted patient can precipitate Wernicke encephalopathy. This rule is non-negotiable.